T otal knee arthroplasty (TKA) is a successful procedure for treating patients with advanced osteoarthritis 1 . The number of knee replacements in the U.S. has risen over the past decade and is projected to increase 6-fold from 2005 to 2030 because of the aging population 2 . Pain in the postoperative period following TKA is a substantial problem and is known to interfere with patients' ability to sleep and walk and with their rehabilitation 3 . Traditionally used analgesic techniques such as patientcontrolled analgesia with intravenous opioids, peripheral nerve blocks, and neuraxial anesthetic techniques come with an inherent risk of side effects and delays in hospital discharge.
Systemic and neuraxial blocks may produce nausea, pruritus, vomiting, dizziness, urinary retention, sedation, poor muscle control, and/or constipation [4] [5] [6] [7] . On the other hand, plexus and proximal nerve blocks may cause quadriceps weakness that increases the risk of inpatient falls [8] [9] [10] . Preservation of quadriceps function is thought to facilitate early mobilization. Adductor canal blocks and periarticular infiltration have become popular because they maintain quadriceps strength while providing postoperative analgesia similar to that of femoral nerve blocks 3, [11] [12] [13] [14] [15] [16] . While adductor canal blocks are known to cover most of the anteromedial aspect of the knee joint, they do not provide the coverage of the lateral and posterior aspects of the knee that is obtained with periarticular infiltration. To overcome this drawback, the adductor canal block is commonly combined with posterior knee injections with or without lateral femoral cutaneous nerve blocks to cover the lateral and posterior aspects of the knee joint (a motor-sparing knee block) to provide regional analgesia following TKA 17 . We are not aware of any previous studies comparing the adductor canal block or motor-sparing block with periarticular infiltration for analgesia following TKA. Our hypothesis was that singleinjection motor-sparing blocks would provide analgesia similar to that obtained with single-injection periarticular infiltration following primary TKA. Our primary objective was to compare the duration of analgesia between the 2 techniques following TKA. We also compared quadriceps strength, function, pain, satisfaction, side effects, and length of hospital stay.
Materials and Methods

T
his single-center randomized clinical trial of patients undergoing a primary TKA was performed between July 2014 and June 2015. It was approved by the Health Sciences Research Ethics Board for Research Involving Human Subjects. The clinical trial number for this study is NCT02540070 at ClinicalTrials.gov.
We included patients from 18 to 85 years of age with American Society of Anesthesiologists (ASA) I, II, or III physical status who were scheduled to undergo elective primary TKA. Patients with psychiatric illness, cognitive impairment, narcotic dependency, extraneous sources of chronic pain, allergies to study drugs, or any contraindications to nerve blocks or multimodal analgesia were excluded. Patients who were wheelchair bound, had a language barrier, or were unwilling to provide informed consent were also not considered. Patients were recruited from the practices of 4 orthopaedic surgeons who specialized in joint arthroplasty.
Eligible patients were randomized via web-based software (www. empowerhealthresearch.ca) prior to their TKA by 1 of 2 research assistants not involved in the assessment of outcomes. The randomization contained mixed block sizes of 2 and 4 with a 1:1 allocation ratio to receive either (1) the motor-sparing block (experimental group) or (2) the periarticular infiltration (control group). Randomization was stratified by sex and by surgeon.
Motor-Sparing Block (Experimental Group)
The modified adductor canal block (motor-sparing block) was performed preoperatively in a block room under ultrasound guidance and with use of titrated sedation with midazolam and fentanyl. It included a midthigh adductor canal block combined with posterior pericapsular and lateral femoral cutaneous injections. The motor-sparing block consisted of 0.5% ropivacaine, 2.5 mg/mL of epinephrine, 10 mg of morphine, and 30 mg of ketorolac, for a total anesthetic volume of 60 mL.
Adductor canal block: The adductor canal block was administered through a midthigh approach with use of an in-plane technique in which the adductor canal was identified under the sartorius muscle 8 to 10 cm proximal to the takeoff of the descending genicular artery from the superficial femoral artery. Five milliliters of the study drug was injected above the fascia lata between the sartorius and rectus femoris muscles to target the intermediate cutaneous nerve. The needle was directed into the fascia of the sartorius to deliver 5 mL of the study drug to cover the medial cutaneous nerve of the thigh. The needle was then advanced until its tip was adjacent to the femoral artery within the adductor canal, and 20 mL of the study drug was injected. A catheter was inserted 3 cm beyond the tip of the needle, and the position was confirmed using color Doppler ultrasound.
Posterior pericapsular injection: An 8-cm block 18-gauge needle was inserted near the medial femoral epicondyle (10 cm from the joint line) under ultrasound guidance. At this site, 20 mL of the study drug was injected between the bone and popliteal artery.
Lateral femoral cutaneous nerve block: The lateral femoral cutaneous nerve was identified between the origin of the sartorius and the tensor fasciae latae muscle, and 10 mL of the study drug was injected. This was to cover the lateral cutaneous aspect of the knee joint. Sham periarticular injections of isotonic saline solution (100 mL) were administered intraoperatively to blind Participant flow through the study. Some patients were ineligible for >1 reason.
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both the surgeon and anesthetist to the study group to which the patient had been assigned.
Periarticular Infiltration (Control Group)
To ensure blinding, patients randomized to the control group underwent a preoperative injection of isotonic saline solution (60 mL), with use of titrated sedation with midazolam and fentanyl, in place of the motor-sparing block. These patients received periarticular infiltration of study-labeled local anesthetics consisting of a 100-mL mixture of 0.3% ropivacaine, 2.5 mg/mL of epinephrine, 10 mg of morphine, and 30 mg of ketorolac administered by the surgeon using a moving needle technique intraoperatively as performed at our institution 18 . The first 20-mL aliquot of the mixture was injected into the posterior aspect of the capsule and the medial and lateral collateral ligaments just prior to component implantation. The quadriceps mechanism and retinacular tissues were then infiltrated with an additional 20 mL. The remaining 60 mL was used to infiltrate the fat and subcuticular tissues. All surgeons had considerable expertise performing periarticular infiltration.
Two of the surgeons had participated in a study by Busch et al. 18 , who demonstrated that our technique significantly reduced the requirements for patient-controlled analgesia and improved satisfaction following TKA. All study patients received preoperative multimodal analgesia consisting of Tylenol (acetaminophen; 975 mg), naproxen (500 mg), gabapentin (600 mg), and granisetron (2 mg). The same local anesthetic mixtures were used in both groups to ensure comparability of systemic effects. A femoral tourniquet was inflated for the duration of all of the TKAs. All patients received spinal anesthesia with 15 mg of hyperbaric bupivacaine with titrated sedation intraoperatively.
An independent anesthetist prepared and concealed the study drugs from the outcome assessor and study anesthetist. The study anesthetists performed the motor-sparing block or sham intervention; patients randomized to receive the motor-sparing block underwent periarticular infiltration using isotonic saline solution. All anesthetists had completed (or were completing) fellowships at orthopaedic centers where ultrasound-guided blocks for TKAs 1276
are commonly performed. The patient's orthopaedic surgeon performed the infiltration or sham infiltration; patients allocated to undergo periarticular infiltration received a motor-sparing block using isotonic saline. Block mixtures and isotonic saline solution are visually indistinguishable. Therefore, the patient, surgeon, block anesthetist, and outcome assessor all remained blinded. The primary outcome was duration of analgesia. Time 0 was defined as the end of the administration of the motor-sparing block by the anesthetist or completion of the periarticular infiltration by the surgeon. Patients were assessed for pain during rest and activity (45°of knee flexion) at baseline; on arrival in the post-anesthesia care unit; and then at 2, 4, 6, 12, 18, 24, 30, 36, and 48 hours. If patients were not discharged at or before 48 hours, pain was assessed at 72 hours as well. Pain was measured using an 11-point numerical rating scale (0 to 10 points) by a blinded assessor.
The end of analgesia was defined as patient-reported pain at rest or activity rated as ‡6 on the numerical rating scale 11, 19 and initiation of the first rescue analgesia (continuous adductor canal block [10-mL bolus of 0.2% ropivacaine and subsequent infusion at a basal rate of 6 mL/hour] with patientcontrolled boluses of 4 mL every 30 minutes as needed). Secondary rescue analgesia consisted of 5 to 10 mg of oxycodone as needed if pain was still poorly controlled.
We recorded the level of pain immediately following physiotherapy on the 11-point numerical rating scale. If pain persisted after the first 2 rescue regimens (adductor canal block and oxycodone) the ward nurse administered Hydromorph Contin (hydromorphone). Overall satisfaction with postoperative pain control was measured using an 11-point numerical rating scale with 0 indicating extremely dissatisfied and 10 indicating extremely satisfied 13, 19, 20 .
We measured maximum voluntary isometric contraction with a handheld dynamometer (Commander Echo Muscle Testing Dynamometer; JTECH Medical) before and 20 minutes after the administration of the blocks as described by Grevstad et al. 11 . After surgery, we repeated this measurement at 6 hours after the initial block and then at 0800 and 1600 hours daily until a pain rating of ‡6 indicated that block analgesia had ended.
Patients completed Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) 7 and Short Form-12 version 2 (SF-12v2) 21, 22 questionnaires preoperatively and 3 months postoperatively as well as the satisfaction section of the postoperative Knee Society Score (KSS) 23, 24 at discharge and 3 months postoperatively.
We recorded the time until the patient first became mobile, defined as the ability to walk a distance of >5 m. All patients attempted to perform the timed "Up & Go" test (TUG)-with use of a standardized chair and with the assistive device recorded-during the first physiotherapy appointment on postoperative day 1 and again at discharge. If a patient was unable to perform the test, that was recorded and the reason was documented.
We recorded the number of days until patients were eligible for discharge as the length of the hospital stay. Also, at each assessment until discharge, we recorded the intensity of nausea on a 4-point scale (0 = no nausea or vomiting, 1 = nausea but no vomiting, 2 = vomiting, and 3 = persistent vomiting) 13, [25] [26] [27] and presence of pruritus (yes or no). We recorded all adverse events as well. According to Zhang et al. 16 , the duration of the analgesic effect from single-injection periarticular infiltration (control group) can range from 8 to 24 hours, and in an unpublished pilot study, clinicians at our institution found the mean duration (and standard deviation [SD]) to be 16 ± 5.5 hours. An equality sample-size calculation was performed using a 2-sided alpha of 0.05 and 80% power to detect a minimal clinically important difference between groups of 4 hours and an SD of 5.5 hours. Thirty patients per group were required, but we planned to recruit 40 patients per group to account for potential withdrawals. All patients were analyzed on an intention-to-treat basis. Descriptive statistics of each group were represented with means and SDs for continuous variables and proportions for nominal variables. An analysis of covariance (ANCOVA) with post-hoc Bonferroni correction was performed to compare the 2 groups for all outcomes. The outcome served as the dependent variable; group allocation, as the independent variable; and baseline pain and tourniquet time, as the covariates. Baseline scores were used as covariates for the WOMAC and SF-12 scores. Non-normally distributed variables were compared using the Mann-Whitney U test. We used the last outcome carried forward to impute the final pain score if it was missing (n = 3). We used SPSS version 23.0 (IBM Analytics) for data analysis. Statistical significance was set at p < 0.05.
Results
F
rom July 2014 to March 2015, we screened 334 patients for this study (Fig. 1) . Eighty-seven eligible patients gave their consent. Five were withdrawn prior to randomization (4 declined surgery and 1 rescheduled the surgery), and 12 were withdrawn after randomization (8 declined spinal or block anesthesia, 2 had surgery scheduling issues, and 2 had their first rescue medication erroneously initiated immediately postoperatively). Patient demographics, comorbidities, and block characteristics were similar between groups (Tables I  and II) .
The mean duration of analgesia was significantly longer for the patients who received the motor-sparing block (18.1 ± 1.7 hours) compared with those who received the periarticular infiltration (9.25 ± 1.7 hours), with a mean difference of 8.8 hours (95% confidence interval [CI] = 3.98 to 13.62 hours, p < 0.01) (Fig. 2) . The patients treated with the motorsparing block also had significantly lower numerical ratings for pain at rest at 2 hours postoperatively and for pain during activity at 2 and 4 hours postoperatively. There were no significant differences between groups with regard to pain at rest or with activity at any other time points or following physiotherapy (Fig. 3) .
There was no difference between the 2 groups with respect to the secondary outcome measures of quadriceps strength (Fig. 4) , oxycodone consumption, SF-12 or WOMAC score, time until the patient was first mobilized or the distance that he/she could walk, TUG-test results, patient satisfaction, or length of hospital stay (Table III) .
Two patients in the motor-sparing-block group experienced an adverse event: 1 had a deep vein thrombosis that delayed discharge from the hospital, and the other was diagnosed with suspected interstitial lung disease after discharge. One patient in the periarticular infiltration group fell but was discharged without delay on postoperative day 2. No other complications occurred in either group.
Discussion
W e compared the duration of analgesia following TKA in patients randomized to receive either a periarticular infiltration or a motor-sparing block. The motor-sparing block provided a longer duration of analgesia, whereas the secondary outcome measures of quadriceps strength and early functional recovery were comparable between the 2 groups. More patients receiving periarticular infiltration had early pain (at 2 to 4 hours) during rest and activity.
Pain following TKA is usually managed with multimodal analgesia with peripheral nerve blocks or periarticular infiltration. Femoral nerve blocks are commonly performed for analgesia following TKA at many centers worldwide 28 , and they have been shown to be better than systemic analgesia alone or epidurals 28, 29 . Alternatives to femoral nerve blocks, including intrathecal opioids, epidural analgesia, periarticular infiltration, and adductor canal blocks, have been popular for knee analgesia. Recent systematic reviews have shown that periarticular infiltration and femoral nerve blocks provide similar analgesia at rest within the first 24 hours following TKA 15, [30] [31] [32] , with femoral nerve blocks possibly providing better analgesia for pain with movement 33, 34 . Adductor canal blocks have been noted to be equivalent to 35, 36 or better 37,38 than femoral nerve blocks in terms of pain scores within the first 24 postoperative hours.
We found no previous studies comparing the analgesic profile of adductor canal blocks with that of periarticular infiltration following TKA and thought that such a comparison was necessary. Without published data on the duration of analgesia from adductor canal blocks, we were uncertain whether our motor-sparing block would provide a greater duration of pain relief than periarticular infiltration. Studies that have suggested more conclusive evidence of improved pain-control performance of adductor canal blocks over femoral nerve blocks in comparison with periarticular infiltration over femoral nerve blocks 37, 38 agree with our findings of a greater mean duration of analgesia in our motor-sparing-block group (18.1 ± 1.7 hours) than in our periarticular infiltration group (9.25 ± 1.7 hours).
We found the motor-sparing block to be associated with significantly better pain scores during activity at 2 and 4 hours postoperatively and during rest at 2 hours after the TKA. This is likely explained by a shorter duration of relief of pain with activity (wearing off for most patients by the first 8 hours after the TKA) in patients who received periarticular infiltration than in those who had nerve blocks 33, 34 . Only 2 patients in the motor-sparing-block group and 1 patient in the periarticular infiltration group did not require rescue medication prior to discharge.
Studies have shown that patients who have had an adductor canal block or periarticular infiltration retain more quadriceps strength than patients with a femoral nerve block since a majority of the quadriceps innervation (all except for the nerve to the vastus medialis) is spared 11, 13, 26, 27 . Because the 2 other injections used in our motor-sparing block do not target any additional motor nerves, we did not see any differences in quadriceps strength. The 2 analgesic modalities in our study showed similar performances regarding the time to mobilization, length of hospital stay, and functional recovery (TUG, WOMAC, and SF-12) scores. Preservation of quadriceps function with an adductor canal block or periarticular infiltration is known to lead to a better range of motion than is seen after a femoral nerve block 28, 34, 37, 39 . It should be noted that the greatest decrease in quadriceps power is due to the TKA itself 13 , as our results show. The impact of analgesic modalities on the length of stay may have been minimized in our study since the physiotherapy and nursing care were not optimized to promote early discharge; instead, they followed our institutional standard of care. We did not note any differences in overall nausea, vomiting, or pruritus between groups because both interventions were opiate-sparing 4, 5, 7, 40 . The number of opiates used by our patients was low since the first rescue medication that the patients received was non-narcotic (ropivacaine).
Although our study is, to our knowledge, the first to compare the analgesic efficacy of a modified adductor canal block with that of periarticular infiltration, it had certain limitations. First, the "end of analgesia" was defined by a numerical pain rating of ‡6, which could have led to inflation of analgesic duration if patients were in pain but it had not yet reached a severity of 6 on an 11-point scale. Furthermore, the "start of analgesia" may have led to a small lead-time bias in favor of the motor-sparing block since this intervention began 1 to 2 hours prior to the start of surgery. Finally, use of a continuous adductor canal block as a first rescue analgesia might have led to a lack of difference in opioid consumption between groups as continuous adductor canal blocks are shown to decrease the prevalence of severe pain 11 . In conclusion, a motor-sparing block is a feasible analgesic modality for patients undergoing primary TKA. In the context of background multimodal analgesia, motor-sparing blocks provide a significantly longer duration of analgesia than periarticular infiltration while preserving muscle function and not negatively affecting length of stay, satisfaction, side effects, or functional rehabilitation. n
